In summary, we identified five key genes (SFN, ARHGAP9, VSIG4, ISG20, CD3G) that can distinguish patients with renal fibrosis from controls, making them potential biomarkers for disease diagnosis and treatment monitoring. This evidence concerns the gene VSIG4 and renal fibrosis.